In our study, the positivity rate for JAK-2 mutation reached 13%, which is less than previously reported in other cases of systemic venous thrombosis (23) but higher than expected, especially in the cases of first-ever thrombosis with normal blood counts. The gene discussed is JAK2; the disease is deep vein thrombosis.